Widely used:Recently Viewed
Clear All
$4.13
$-0.17
(-3.95%)
As on 17-Apr-2025 16:10EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$18 Mln
P/E Ratio
--
P/B Ratio
3
Industry P/E
--
Debt to Equity
-1.55
ROE
-0.32 %
ROCE
-23.35 %
Div. Yield
0 %
Book Value
--
EPS
-2.27
CFO
CN¥-922.74 Mln
EBITDA
CN¥-1,498.04 Mln
Net Profit
CN¥-2,962.59 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Concord Medical Services Holdings Limited - ADR
| -23.23 | -6.98 | -8.22 | -34.78 | -37.60 | -25.34 | -24.35 |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Concord Medical Services Holdings Limited - ADR
| -50.80 | -32.93 | -18.00 | -27.01 | 2.71 | -25.06 | 6.87 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services... include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China. Read more
Chairman & CEO
Dr. Jianyu Yang
Chief Financial Officer
Mr. Boxun Zhang
Headquarters
Beijing
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Concord Medical Services Holdings Limited - ADR stood at $ 6,054 Mln as on 31-Dec-23
The share price of Concord Medical Services Holdings Limited - ADR is $4.13 (NYSE) as of 17-Apr-2025 16:10 EDT. Concord Medical Services Holdings Limited - ADR has given a return of -37.6% in the last 3 years.
Concord Medical Services Holdings Limited - ADR has a market capitalisation of $ 18 Mln as on 17-Apr-2025. As per Value Research classification, it is a company.
Since, TTM earnings of Concord Medical Services Holdings Limited - ADR is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Concord Medical Services Holdings Limited - ADR and enter the required number of quantities and click on buy to purchase the shares of Concord Medical Services Holdings Limited - ADR.
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
The CEO & director of Dr. Jianyu Yang. is Concord Medical Services Holdings Limited - ADR, and CFO & Sr. VP is Mr. Boxun Zhang.
There is no promoter pledging in Concord Medical Services Holdings Limited - ADR.
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Concord Medical Services Holdings Limited - ADR | Ratios |
|---|---|
|
Return on equity(%)
|
14.94
|
|
Operating margin(%)
|
-86.15
|
|
Net Margin(%)
|
-55.39
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Concord Medical Services Holdings Limited - ADR was No Profit.
